SILVAGNI, Ettore
 Distribuzione geografica
Continente #
NA - Nord America 3.747
AS - Asia 3.160
EU - Europa 1.301
SA - Sud America 470
AF - Africa 281
OC - Oceania 31
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.992
Nazione #
US - Stati Uniti d'America 3.540
SG - Singapore 1.024
CN - Cina 544
IT - Italia 474
VN - Vietnam 292
BR - Brasile 270
HK - Hong Kong 223
DE - Germania 159
ID - Indonesia 158
EG - Egitto 154
GB - Regno Unito 152
BD - Bangladesh 149
IN - India 149
JP - Giappone 126
FR - Francia 108
IQ - Iraq 96
MX - Messico 90
CA - Canada 86
FI - Finlandia 82
TR - Turchia 70
EC - Ecuador 52
RU - Federazione Russa 52
NL - Olanda 46
PK - Pakistan 46
IR - Iran 43
PH - Filippine 43
ZA - Sudafrica 42
AR - Argentina 39
PL - Polonia 38
SA - Arabia Saudita 37
AU - Australia 29
CO - Colombia 29
ES - Italia 28
TW - Taiwan 28
KR - Corea 27
MY - Malesia 27
UA - Ucraina 27
PE - Perù 26
AT - Austria 22
KE - Kenya 18
BO - Bolivia 17
SE - Svezia 17
CL - Cile 14
VE - Venezuela 14
CH - Svizzera 12
CZ - Repubblica Ceca 12
NG - Nigeria 12
BE - Belgio 11
DZ - Algeria 11
MA - Marocco 11
JO - Giordania 10
HU - Ungheria 9
JM - Giamaica 8
RO - Romania 8
IE - Irlanda 7
IL - Israele 7
PS - Palestinian Territory 7
KZ - Kazakistan 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
GR - Grecia 5
HN - Honduras 5
LB - Libano 5
LT - Lituania 5
LY - Libia 5
OM - Oman 5
TH - Thailandia 5
UY - Uruguay 5
UZ - Uzbekistan 5
AL - Albania 4
CR - Costa Rica 4
DK - Danimarca 4
ET - Etiopia 4
LV - Lettonia 4
MG - Madagascar 4
NP - Nepal 4
AZ - Azerbaigian 3
MM - Myanmar 3
PA - Panama 3
PT - Portogallo 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
VC - Saint Vincent e Grenadine 3
BF - Burkina Faso 2
BG - Bulgaria 2
CY - Cipro 2
KG - Kirghizistan 2
KH - Cambogia 2
LS - Lesotho 2
NZ - Nuova Zelanda 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TG - Togo 2
UG - Uganda 2
AQ - Antartide 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
Totale 8.973
Città #
Singapore 617
Ashburn 568
San Jose 444
Dallas 354
Santa Clara 241
Hong Kong 200
Beijing 191
Los Angeles 110
Fairfield 108
Chandler 103
Council Bluffs 102
Ho Chi Minh City 102
Tokyo 98
New York 86
Jakarta 85
Hanoi 74
Woodbridge 65
Alexandria 52
Helsinki 52
Houston 52
Lauterbourg 52
Seattle 48
Baghdad 45
Ferrara 44
Cairo 42
Wilmington 40
Shanghai 38
Cambridge 37
Mexico City 34
Munich 34
Ann Arbor 33
Warsaw 33
Chicago 32
London 32
São Paulo 32
Buffalo 31
Orem 29
Montreal 28
Princeton 28
Bologna 27
Atlanta 26
Toronto 25
Frankfurt am Main 24
Hefei 24
Milan 23
Brooklyn 21
Lappeenranta 21
Jacksonville 19
Poplar 19
Falkenstein 18
Izmir 18
Johannesburg 18
Nanjing 18
Rome 18
Boston 17
Da Nang 17
Denver 17
Quito 17
Lima 16
Naples 16
Manchester 15
Sydney 15
Ankara 14
Chennai 14
Nairobi 14
Najaf 14
San Diego 14
Athens 13
Miami 13
New Delhi 13
Nuremberg 13
Padova 13
Phoenix 13
Haiphong 12
Kuala Lumpur 12
Riyadh 12
Amsterdam 11
City of London 11
Guayaquil 11
Lahore 11
Secaucus 11
Delhi 10
Hillah 10
Melbourne 10
Moscow 10
Mumbai 10
Rio de Janeiro 10
San Francisco 10
Stockholm 10
Surabaya 10
Tanta 10
Vienna 10
Budapest 9
Columbus 9
Cuenca 9
Dhaka 9
Edinburgh 9
Elk Grove Village 9
Istanbul 9
La Paz 9
Totale 5.266
Nome #
Systemic lupus erythematosus: one year in review 2023 948
Peripheral nervous system involvement in systemic lupus erythematosus: a review of the evidence 340
Novel insights into the management of rheumatoid arthritis: one year in review 2022 290
The diagnosis and clinical management of the neuropsychiatric manifestations of lupus 281
Novel insights into the management of rheumatoid arthritis: one year in review 2023 264
Combination of clinical factors predicts successful glucocorticoid withdrawal in systemic lupus erythematosus (SLE): results from a multicentre, retrospective cohort study 219
Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases 197
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus 188
Influence of aromatase inhibitors therapy on the occurrence of rheumatoid arthritis in women with breast cancer: results from a large population-based study of the Italian Society for Rheumatology 181
From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis 180
Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome 178
High-grade synovitis associates with clinical markers and response to therapy in chronic inflammatory arthritis: post hoc analysis of a synovial biomarkers prospective cohort study 176
Optimizing Patient Care: A Systematic Review of Multidisciplinary Approaches for SLE Management 175
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology 175
Biological and synthetic target DMARDs in psoriatic arthritis 171
Longitudinal changes in cerebral white matter microstructure in newly diagnosed systemic lupus erythematosus patients 156
Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis 155
Evaluation of the Synovial Effects of Biological and Targeted Synthetic DMARDs in Patients with Psoriatic Arthritis: A Systematic Literature Review and Meta-Analysis 153
Comparison of the risks of hospitalisation for cardiovascular events in patients with rheumatoid arthritis treated with tocilizumab and etanercept 153
Systemic lupus erythematosus: one year in review 2024 151
Focus on Sex and Gender: What We Need to Know in the Management of Rheumatoid Arthritis 150
Tofacitinib restores psoriatic arthritis fibroblast-like synoviocytes function via autophagy and mitochondrial quality control modulation 150
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 148
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 145
Therapeutic Strategies and Outcomes in Neuropsychiatric Systemic Lupus Erythematosus: An International Multicenter Retrospective Study 144
Adherence of Italian rheumatologists to the EULAR recommendations and outcomes in early rheumatoid arthritis patients after starting conventional DMARDs: Methotrexate in Italian patients wiTh Rheumatoid Arthritis (the MITRA study). A cohort study of the Italian Society for Rheumatology 144
One year in review 2018: novelties in the treatment of rheumatoid arthritis 142
Conventional brain magnetic resonance imaging in the longitudinal evaluation of newly diagnosed systemic lupus erythematosus patients: a retrospective analysis from a single-centre cohort 142
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression 140
Cerebrospinal Fluid Analysis in Rheumatological Diseases with Neuropsychiatric Complications and Manifestations: A Narrative Review 138
Serum Antibodies Against the Oncogenic Merkel Cell Polyomavirus Detected by an Innovative Immunological Assay With Mimotopes in Healthy Subjects 136
Methotrexate in Italian patients wiTh Rheumatoid Arthritis (MITRA study): an observational study about the use of methotrexate in early RA patients and the adherence to the EULAR 2013 recommendations. A project of the Italian Society for Rheumatology 135
Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles 132
Cerebral Microstructure Analysis by Diffusion-Based MRI in Systemic Lupus Erythematosus: Lessons Learned and Research Directions 131
Tofacitinib improves mitochondrial function in psoriatic arthritis fibroblast-like synoviocytes via autophagy modulation 131
Relevant domains and outcome measurement instruments in neuropsychiatric systemic lupus erythematosus: a systematic literature review 122
Features associated with different inflammatory phenotypes of calcium pyrophosphate deposition (CPPD) disease: study using data from the international ACR/EULAR CPPD classification criteria cohort 117
Clinical application of synovial biopsy in noninflammatory and persistent inflammatory refractory rheumatoid arthritis 115
Neurologic Involvement in Rheumatic Diseases 114
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 112
Can conventional brain MRI support the attribution process in neuropsychiatric SLE? A multicentre retrospective study 112
Systemic lupus erythematosus: one year in review 2025 109
The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease 97
Risk of hospitalisation for serious bacterial infections in patients with rheumatoid arthritis treated with biologics. Analysis from the RECord linkage On Rheumatic Disease study of the Italian Society for Rheumatology 95
The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease 94
Musculoskeletal ultrasound for treating rheumatoid arthritis to target—a systematic literature review 92
Use of Ultrasonography to Discriminate Psoriatic Arthritis from Fibromyalgia: A Post-Hoc Analysis of the ULISSE Study 90
One year in review 2021: novelties in the treatment of rheumatoid arthritis 90
Persistence of bDMARD therapy in Rheumatoid Arthritis after first-line TNF-inhibitor failure: the RECORD study of the Italian Society for Rheumatology 89
One year in review 2019: novelties in the treatment of rheumatoid arthritis 87
Rheumatoid Arthritis and Cardiovascular Risk: Retrospective Matched-Cohort Analysis Based on the RECORD Study of the Italian Society for Rheumatology 85
Role of comorbidities on therapeutic persistence of biological agents in rheumatoid arthritis: results from the RECord-linkage On Rheumatic Disease study on administrative healthcare databases 81
One year in review 2020: novelties in the treatment of rheumatoid arthritis 75
Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage 73
SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study 72
Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosus 69
Pulmonary arterial hypertension in systemic lupus erythematosus: identification of risk factors and haemodynamics characteristics in a multicentre retrospective cohort 63
Efficacy of Belimumab on Different Joint and Skin Manifestations of Systemic Lupus Erythematosus: Real-Life Data from a New Multicentric, Nationwide Italian Cohort (BeRLiSS-JS 2.0) 46
Switch from Intravenous to Subcutaneous Formulation of Tocilizumab in Rheumatoid Arthritis: Retrospective Cohort Analysis and Systematic Literature Review 45
Role of musculoskeletal ultrasound in diagnosing and managing chronic inflammatory arthritis in overweight and obese patients: a narrative review 42
Systemic lupus erythematosus: one year in review 2026 36
Early antiproteinuric effect of voclosporin in patients with lupus nephritis in a real-life setting: preliminary results from the VoRLiSS (Voclosporin in Real Life Setting Study) experience 35
Ultrasound for assessing disease activity and structural damage in psoriatic arthritis: the UPsA scores from a multicentre study by the Italian Society of Rheumatology 25
Shaping rheumatoid arthritis treatment: Clinical and demographic drivers of tsDMARDs versus bDMARDs prescription post-EMA pronouncement on JAK inhibitors. Insights from the AMBI-RA study 14
Assessing the sensitivity and the clinical impact of the 2023 ACR/EULAR classification criteria in Obstetric Antiphospholid Syndrome: findings from a multicenter Italian cohort with a long-term follow-up 14
Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study 13
Distinct pattern of comorbidities hinders treatment target attainment in SLE through persistent disease activity and delayed glucocorticoid tapering: longitudinal data from a multicentre cohort study 13
Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohort 9
Glucagon-like peptide-1 receptor agonists in psoriasis and psoriatic arthritis: emerging evidence and future research opportunities. 7
Totale 9.191
Categoria #
all - tutte 39.369
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 303
Totale 39.672


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 0 0 9
2021/2022247 12 34 10 11 10 6 29 21 16 8 14 76
2022/2023245 26 32 15 18 39 17 6 21 27 4 20 20
2023/2024610 21 23 13 8 56 6 9 18 25 140 115 176
2024/20252.172 82 150 200 140 222 252 96 110 343 195 226 156
2025/20265.440 431 210 622 498 784 291 618 331 508 618 521 8
Totale 9.191